350 related articles for article (PubMed ID: 25832075)
1. Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.
Dewji S; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
Med Phys; 2015 Apr; 42(4):1851-7. PubMed ID: 25832075
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Point-Source Method for Estimating Dose Rates to Members of the Public from Exposure to Patients with 131I Thyroid Treatment.
Dewji SA; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
Health Phys; 2015 Sep; 109(3):233-41. PubMed ID: 26222218
[TBL] [Abstract][Full Text] [Related]
3. Organ S values and effective doses for family members exposed to adult patients following I-131 treatment: a Monte Carlo simulation study.
Han EY; Lee C; Mcguire L; Brown TL; Bolch WE
Med Phys; 2013 Aug; 40(8):083901. PubMed ID: 23927361
[TBL] [Abstract][Full Text] [Related]
4. Estimation of External Dose Rates to Hotel Workers from bed linens Contaminated by 131I Patients.
Foreman C; Dewji S
Health Phys; 2020 Jun; 118(6):615-622. PubMed ID: 31658163
[TBL] [Abstract][Full Text] [Related]
5. UPDATED AGE-SPECIFIC EXTERNAL DOSE AND EXPOSURE RATE COEFFICIENTS FOR 131I PATIENT RELEASE.
Aziz L; Dewji S
Radiat Prot Dosimetry; 2022 May; 198(6):311-324. PubMed ID: 35437606
[TBL] [Abstract][Full Text] [Related]
6. A practical guideline for the release of patients treated by I-131 based on Monte Carlo dose calculations for family members.
Han EY; Lee C; Mcguire L; Bolch WE
J Radiol Prot; 2014 Jun; 34(2):N7-17. PubMed ID: 24705486
[TBL] [Abstract][Full Text] [Related]
7. TEDE per cumulated activity for family members exposed to adult patients treated with 131I.
Han EY; Lee C; Bolch WE
Radiat Prot Dosimetry; 2013; 153(4):448-56. PubMed ID: 22821723
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Exposure Rate and Residual Activity in Felines Undergoing 131I Thyroid Ablation Therapy.
Martin TM; Vasudevan L; Chirayath SS
Health Phys; 2015 Aug; 109(2):95-103. PubMed ID: 26107429
[TBL] [Abstract][Full Text] [Related]
9. Organ Dose Estimates for Hyperthyroid Patients Treated with (131)I: An Update of the Thyrotoxicosis Follow-Up Study.
Melo DR; Brill AB; Zanzonico P; Vicini P; Moroz B; Kwon D; Lamart S; Brenner A; Bouville A; Simon SL
Radiat Res; 2015 Dec; 184(6):595-610. PubMed ID: 26579944
[TBL] [Abstract][Full Text] [Related]
10. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
[TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
[TBL] [Abstract][Full Text] [Related]
12. Protection problems in radionuclide therapy: the patient as a gamma-radiation source.
Pochin EE; Kermode JC
Br J Radiol; 1975 Apr; 48(568):299-305. PubMed ID: 1131488
[TBL] [Abstract][Full Text] [Related]
13. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
[TBL] [Abstract][Full Text] [Related]
14. Internal Dose Assessment after 131I-Iodide Misadministration in a Patient With Incompletely Blocked Thyroid Uptake: Personalized Internal Dose Assessment by Estimating Individual-Specific Biokinetics.
Kwon TE; Park M; Kang JK; Cho M; Jang S; Kim KM; Ha WH; Jin YW
Health Phys; 2019 Jun; 116(6):760-770. PubMed ID: 30920994
[TBL] [Abstract][Full Text] [Related]
15. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study on the transition of radiation dose rate and iodine distribution in patients with I-131-treated well-differentiated thyroid cancer to improve bed control shorten isolation periods.
Yama N; Sakata K; Hyodoh H; Tamakawa M; Hareyama M
Ann Nucl Med; 2012 Jun; 26(5):390-6. PubMed ID: 22382609
[TBL] [Abstract][Full Text] [Related]
17. Radiation exposure rate from 131I-treated hyperthyroid patients--a dynamic study, with data for up to 42 d post therapy.
Mohammadi H
Health Phys; 2005 May; 88(5):486-90. PubMed ID: 15824597
[TBL] [Abstract][Full Text] [Related]
18. Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy.
Barquero R; Basurto F; Vega-Carrillo HR; Iñiguez MP; Ferrer N; Esteban R
Health Phys; 2008 Aug; 95(2):227-33. PubMed ID: 18617804
[TBL] [Abstract][Full Text] [Related]
19. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism.
Stabin MG; Watson EE; Marcus CS; Salk RD
J Nucl Med; 1991 May; 32(5):808-13. PubMed ID: 2022987
[TBL] [Abstract][Full Text] [Related]
20. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.
Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ
Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
